Therefore, practitioners have had to prescribe many of these ophthalmic preparations empirically. In 1997, the U.S. Congress enacted a new law providing marketing incentives for pediatric drug ...
an injectable targeted at thyroid eye disease (TED). At the virtual event, the company will also disclose a design for its Phase 3 LONGITUDE program for the drug, developed using FDA feedback ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback